环球健康服务(UHS)最主要的收入来源是什么？

通过最新财报数据拆解，该公司的收入主要由其核心业务板块与相关服务支持构成。您可以通过页面上的交互式图表直观查看各业务线对总营收的具体贡献比例。

如何直观分析 UHS 的财务状况与盈利模式？

瓜壳日历通过交互式桑基图(Sankey Diagram)和瀑布图(Waterfall Chart)，将该公司的总营收、销售成本、运营费用以及最终的净利润流程进行了全景可视化，方便投资者一分钟看懂其经营效率与现金流走向。

Income Statement Q1 2026
Item	Category	Value	YoY
Net revenues	revenue	4.50B	9.65%
Other (income) expense, net	revenue	3.39M	-40.11%
Operating income (loss)	profit	502.86M	10.56%
Operating expenses, total	cost	3.99B	9.53%
Aggregate	profit	506.25M	9.94%
Reportable segment income before income taxes	profit	469.12M	11.58%
Interest expense, net	cost	37.13M	-7.30%
Net income attributable to uhs	profit	358.68M	11.52%
Provision for income taxes	cost	110.44M	11.78%
Net income attributable to uhs	profit	348.68M	10.11%
Less: net income (loss) attributable to noncontrolling interests	cost	10.00M	102.02%

Business Breakdown
Segment	Value	YoY
Acute Care Hospital Services	2.61B	10.70%
Behavioral Health Services	1.88B	8.23%
Other Operating	2.89M	1.83%

Geography Breakdown
Segment	Value	YoY
UNITED KINGDOM	261.00M	14.98%
Others	4.23B	9.33%

Products Breakdown
Segment	Value	YoY
Managed Care	1.20B	1.32%
Medicaid	709.90M	34.73%
Managed Medicaid	646.60M	7.26%
Managed Medicare	550.10M	5.73%
Medicare	481.68M	2.91%
Other Patient Revenue And Adjustments Net	329.34M	6.21%
Other Non Patient Revenue	315.85M	21.62%
U K Revenue	261.21M	15.04%

Balance Sheet Q1 2026
Item	Category	Value
Property and equipment	assets	13.61B
Accounts receivable, net	assets	2.75B
Other current assets	assets	406.17M
Supplies	assets	229.41M
Cash and cash equivalents	assets	119.03M
Property, plant and equipment, net, total	assets	7.06B
Accumulated depreciation, depletion and amortization, property, plant, and equipment, total	assets	6.55B
Total current assets	assets	3.50B
Goodwill	assets	3.98B
Other	assets	684.25M
Right of use assets-operating leases	assets	375.32M
Deferred income taxes	assets	68.34M
Deferred charges	assets	9.23M
Total assets	assets	15.68B
Total equity	liabilities	7.53B
Long-term debt	liabilities	3.95B
Total current liabilities	liabilities	3.24B
Other noncurrent liabilities	liabilities	532.68M
Operating lease liabilities noncurrent	liabilities	344.56M
Redeemable noncontrolling interests	liabilities	73.38M
Deferred income taxes	liabilities	3.23M
Noncontrolling interest	liabilities	66.24M
Uhs common stockholders’ equity	equity	7.46B
Accounts payable and other liabilities	liabilities	2.36B
Current maturities of long-term debt	liabilities	756.24M
Operating lease liabilities	liabilities	72.90M
Federal and state taxes	liabilities	58.59M

Operating Activities – 3M 2026
Item	Value
Net income attributable to uhs	358.68M
Depreciation & amortization	155.43M
Increase decrease in deferred income taxes and accrued income taxes payable	104.77M
Accrued insurance expense, net of commercial premiums paid	62.57M
Stock-based compensation expense	22.50M
Increase (decrease) in accrued interest receivable, net	10.99M
Other, net	-221000
Gain loss on sale of assets and business	-5.05M
Increase (decrease) in prepaid expense and other assets	-12.26M
Increase (decrease) in self insurance settlement net of reimbursements	-49.02M
Increase (decrease) in other operating assets and liabilities, net, total	-122.91M
Increase (decrease) in accounts receivable	-123.86M

Investing Activities – 3M 2026
Item	Value
Payments for (proceeds from) hedge, investing activities, total	14.72M
Proceeds received from sales of assets and businesses	14.30M
Decrease in capital reserves of commercial insurance subsidiary	28000
Costs incurred for purchase and development of enterprise resource planning application	-4.61M
Payments to acquire businesses, net of cash acquired, total	-4.86M
Payments to acquire property, plant, and equipment, total	-217.16M

Financing Activities – 3M 2026
Item	Value
Issuance of common stock	3.78M
Purchase of ownership interests by minority members, net	3.75M
Additional borrowings	40000
Payments of ordinary dividends, noncontrolling interest	-7.91M
Payments of ordinary dividends, common stock	-12.97M
Repayments of long-term debt, total	-44.73M
Payments for repurchase of common stock	-163.85M

Cash Balance – 3M 2026
Item	Value
Cash and cash equivalents, beginning of period	271.32M
Cash and cash equivalents, end of period	252.55M